BLSH vs CME

For growth investors, CME Group Inc.

(CME) is the stronger pick with 6. 4% revenue growth year-over-year, versus -2. 2% for Bullish (BLSH). CME Group Inc. (CME) offers the better valuation at 25. 8x trailing P/E (23. 5x forward), making it the more compelling value choice. Analysts rate Bullish (BLSH) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, CME Group Inc.

is actually cheaper at 23. 5x.

Over the past 5 years, CME Group Inc.

(CME) delivered a total return of +64. 1%, compared to -34. 8% for Bullish (BLSH). Over 10 years, the gap is even starker: CME returned +284. 9% versus BLSH's -39. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 30β versus Bullish's 2. 64β — meaning BLSH is approximately -969% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 18% for Bullish — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), CME Group Inc.

(CME) is pulling ahead at 6. 4% versus -2. 2% for Bullish (BLSH). On earnings-per-share growth, the picture is similar: CME Group Inc. grew EPS 15. 4% year-over-year, compared to -1209. 3% for Bullish. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus -0. 3% for Bullish — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus -0. 0% for BLSH. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, CME Group Inc.

(CME) trades at 23. 5x forward P/E versus 66. 1x for Bullish — 42. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BLSH: 12. 8% to $50. 00.

In this comparison, CME (3.

8% yield) pays a dividend. BLSH does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 30), 3. 8% yield, +284. 9% 10Y return). Bullish (BLSH) carries a higher beta of 2. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CME: +284. 9%, BLSH: -39. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BLSH (Technology) and CME (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BLSH is a small-cap quality compounder stock; CME is a mid-cap income-oriented stock. CME pays a dividend while BLSH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.